The Complex Landscape of PTEN mRNA Regulation

Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a036236. doi: 10.1101/cshperspect.a036236.

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a key tumor suppressor in the development and progression of different tumor types. Emerging data indicate that small reductions in PTEN protein levels can promote cancer. PTEN protein levels are tightly controlled by a plethora of mechanisms beginning with epigenetic and transcriptional regulation and ending with control of protein synthesis and stability. PTEN messenger RNA (mRNA) is also subject to exquisite regulation by microRNAs, coding and long noncoding RNAs, and RNA-binding proteins. Additionally, PTEN mRNA is markedly influenced by alternative splicing and variable polyadenylation. Herein we provide a synoptic description of the current understanding of the complex regulatory landscape of PTEN mRNA regulation including several specific processes that modulate its stability and expression, in the context of PTEN loss-associated cancers.

Publication types

  • Review

MeSH terms

  • Humans
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • PTEN Phosphohydrolase / biosynthesis
  • PTEN Phosphohydrolase / genetics*
  • RNA, Long Noncoding / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics*
  • RNA-Binding Proteins / genetics
  • Tumor Suppressor Proteins / biosynthesis
  • Tumor Suppressor Proteins / genetics

Substances

  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Messenger
  • RNA-Binding Proteins
  • Tumor Suppressor Proteins
  • PTEN Phosphohydrolase
  • PTEN protein, human